Intravesical injection of onabotulinumtoxinA in neurogenic overactive bladder patients with human T‐cell leukemia virus type 1‐associated myelopathy: A single‐institution case series
Article in IJU Case Reports (May 2021)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus‐1 associated myelopathy
Article in LUTS Lower Urinary Tract Symptoms (February 2018)
Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder
Article in The Brazilian Journal of Infectious Diseases (February 2018)